ATE277942T1 - Pseudopeptide mit inhibierender wirkung auf protein-tyrosinkinasen und sie enthaltende pharmazeutische zusammensetzungen - Google Patents

Pseudopeptide mit inhibierender wirkung auf protein-tyrosinkinasen und sie enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE277942T1
ATE277942T1 AT99962285T AT99962285T ATE277942T1 AT E277942 T1 ATE277942 T1 AT E277942T1 AT 99962285 T AT99962285 T AT 99962285T AT 99962285 T AT99962285 T AT 99962285T AT E277942 T1 ATE277942 T1 AT E277942T1
Authority
AT
Austria
Prior art keywords
pseudopeptides
pharmaceutical compositions
compositions containing
tyrosine kinases
protein tyrosine
Prior art date
Application number
AT99962285T
Other languages
English (en)
Inventor
Christiane Garbay
Wang-Qing Liu
Michel Vidal
Bernard P Roques
Original Assignee
Inst Nat Sante Rech Med
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Centre Nat Rech Scient filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE277942T1 publication Critical patent/ATE277942T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT99962285T 1998-12-24 1999-12-24 Pseudopeptide mit inhibierender wirkung auf protein-tyrosinkinasen und sie enthaltende pharmazeutische zusammensetzungen ATE277942T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9816459A FR2787793B1 (fr) 1998-12-24 1998-12-24 Composes pseudopeptidiques dotes d'une activite inhibitrice a l'egard des voies activees par les proteines a activite tyrosine kinase et les compositions pharmaceutiques les contenant
PCT/FR1999/003289 WO2000039153A1 (fr) 1998-12-24 1999-12-24 Composes pseudopeptidiques dotes d'une activite inhibitrice a l'egard des voies activees par les proteines a activite tyrosine kinase et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
ATE277942T1 true ATE277942T1 (de) 2004-10-15

Family

ID=9534521

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99962285T ATE277942T1 (de) 1998-12-24 1999-12-24 Pseudopeptide mit inhibierender wirkung auf protein-tyrosinkinasen und sie enthaltende pharmazeutische zusammensetzungen

Country Status (6)

Country Link
EP (1) EP1140980B1 (de)
AT (1) ATE277942T1 (de)
CA (1) CA2356777A1 (de)
DE (1) DE69920748D1 (de)
FR (1) FR2787793B1 (de)
WO (1) WO2000039153A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19933492B4 (de) * 1999-07-16 2008-01-10 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung
CN116813504A (zh) * 2023-07-10 2023-09-29 大连民族大学 基于两相循环法制备Fmoc氨基酸的工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184205B1 (en) * 1994-07-22 2001-02-06 University Of North Carolina At Chapel Hill GRB2 SH3 binding peptides and methods of isolating and using same
US6280964B1 (en) * 1995-04-14 2001-08-28 The Regents Of The University Of California Binding sites for phosphotyrosine binding domains
GB9603227D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use

Also Published As

Publication number Publication date
EP1140980B1 (de) 2004-09-29
CA2356777A1 (fr) 2000-07-06
EP1140980A1 (de) 2001-10-10
FR2787793B1 (fr) 2001-03-23
FR2787793A1 (fr) 2000-06-30
WO2000039153A1 (fr) 2000-07-06
DE69920748D1 (de) 2004-11-04

Similar Documents

Publication Publication Date Title
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
DE3881489D1 (de) Peptide mit collagenase hemmender wirkung.
MY109846A (en) Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
PL312196A1 (en) Heterocyclic phenyl compounds as inhibitors of cyclooxygenase-2
IL106821A0 (en) Imidazolidine derivatives,their preparation and pharmaceutical compositions containing them
IL105511A (en) 2,4-dioxoimidazolidine derivatives their preparation and pharmaceutical compositions containing them
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
AR017588A1 (es) Compuestos de benzotiazol, inhibidores de la proteina tirosina quinasa, metodo para tratar desordenes asociados con dicha proteina, y las composicionesfarmaceuticas que contienen dichos compuestos
SE8302130L (sv) Farmakologiskt aktiva bifosfonater, forfarande for deras framstellning och farmaceutiska kompositioner innehallande desamma
TR199900920T2 (xx) Nafthiridin t�revleri.
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
MX9701893A (es) Nuevos inhibidores de la prostaglandinsintasa.
TR200401432T4 (tr) Admantan türevleri
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
NO982976L (no) N-acylaminoalkylhydrazinkarboksimidamider
WO1999050269A3 (de) Porphyrine und ihre verwendung als phptosensitizer
MXPA02012910A (es) Amidas de acidobifenilcarboxilico, su preparacion y su uso como medicinas.
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
YU49902A (sh) Supstituisani derivati piperazina kao mtp inhibitori
BG103194A (en) Pharmaceutical products for the treatment and prevention of diseases caused by the impairment of the vascular endothelial cells
PL329894A1 (en) Novel pyrrolic compounds, method of obtaining such compounds and pharmaceutic compositions containing them
DE69920748D1 (de) Pseudopeptide mit inhibierender wirkung auf protein-tyrosinkinasen und sie enthaltende pharmazeutische zusammensetzungen
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
HRP20000733B1 (hr) NOVI DERIVATI OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] [1,2]DIAZEPIN-1-KARBOKSILNE KISELINE, POSTUPAK NJIHOVOG DOBIVANJA I UPOTREBA U DOBIVANJU TERAPEUTSKI AKTIVNIH SPOJEVA

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties